GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » FendX Technologies Inc (XCNQ:FNDX) » Definitions » Valuation Rank

FendX Technologies (XCNQ:FNDX) Valuation Rank


View and export this data going back to 2023. Start your Free Trial

What is FendX Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


FendX Technologies Valuation Rank Related Terms

Thank you for viewing the detailed overview of FendX Technologies's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


FendX Technologies (XCNQ:FNDX) Business Description

Traded in Other Exchanges
Address
2010 Winston Park Drive, 2nd Floor, Oakville, ON, CAN, L6H 5R7
FendX Technologies Inc is a technology company focused on developing surface protection products that protect surfaces from pathogen contamination. It is focused on the research, development and commercialization of surface protection coatings using Licensed Technology. The company is currently developing its anticipated first product, REPELWRAP to protect high-contact surfaces from contamination to reduce the transmission of harmful pathogens. The Company has a growing intellectual property portfolio consisting of licensed nonprovisional national stage patent applications.